These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33394094)

  • 1. Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients.
    Kajal K; Bose S; Panda AK; Chakraborty D; Chakraborty S; Pati S; Sarkar T; Dhar S; Roy D; Saha S; Sa G
    Cancer Immunol Immunother; 2021 Jul; 70(7):1877-1891. PubMed ID: 33394094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
    Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
    Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
    Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
    Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
    Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Langer EM; Kendsersky ND; Daniel CJ; Kuziel GM; Pelz C; Murphy KM; Capecchi MR; Sears RC
    Oncogene; 2018 Feb; 37(8):1005-1019. PubMed ID: 29084210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
    Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
    Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 11. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPTEP1 suppresses high glucose-induced dysfunction in retinal vascular endothelial cells by interacting with STAT3 and targeting VEGFA.
    Sun X; Lu Y; Lei T
    Acta Diabetol; 2021 Jun; 58(6):759-769. PubMed ID: 33576890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
    Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
    Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer.
    Liu L; Tong Q; Liu S; Cui J; Zhang Q; Sun W; Yang S
    PLoS One; 2016; 11(2):e0148774. PubMed ID: 26882471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
    Zhou Z; Mao W; Li Y; Qi C; He Y
    Anat Rec (Hoboken); 2019 Dec; 302(12):2186-2192. PubMed ID: 31266091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
    Jayaraman S; Doucet M; Kominsky SL
    Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; He Q; Yu W
    Gene; 2020 Sep; 754():144851. PubMed ID: 32525044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.